3-[3-Hydroxy-5-(2-methyl-2-propanyl)-1,2-oxazol-4-yl]alanine structure
|
Common Name | 3-[3-Hydroxy-5-(2-methyl-2-propanyl)-1,2-oxazol-4-yl]alanine | ||
---|---|---|---|---|
CAS Number | 83654-14-2 | Molecular Weight | 228.24500 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C10H16N2O4 | Melting Point | N/A | |
MSDS | USA | Flash Point | N/A |
Name | 3-[3-Hydroxy-5-(2-methyl-2-propanyl)-1,2-oxazol-4-yl]alanine |
---|
Molecular Formula | C10H16N2O4 |
---|---|
Molecular Weight | 228.24500 |
Exact Mass | 228.11100 |
PSA | 109.58000 |
LogP | 1.33240 |
Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
RIDADR | NONH for all modes of transport |
Activation of P2RY11 and ATP release by lipoxin A4 restores the airway surface liquid layer and epithelial repair in cystic fibrosis.
Am. J. Respir. Cell. Mol. Biol. 51(2) , 178-90, (2014) In cystic fibrosis (CF), the airway surface liquid (ASL) height is reduced as a result of impaired ion transport, which favors bacterial colonization and inflammation of the airway and leads to progre... |
|
Protein Drug Targets of Lavandula angustifolia on treatment of Rat Alzheimer's Disease.
Iran. J. Pharm. Res. 14(1) , 291-302, (2015) Different treatment strategies of Alzheimer's disease (AD) are being studied for treating or slowing the progression of AD. Many pharmaceutically important regulation systems operate through proteins ... |
|
Ibotenic acid analogues. Synthesis, molecular flexibility, and in vitro activity of agonists and antagonists at central glutamic acid receptors.
J. Med. Chem. 28 , 668, (1985) The syntheses of (RS)-alpha-amino-3-hydroxy-5-tert-butyl-4-isoxazolepropionic acid (9, ATPA), (alpha-RS, beta-RS)-alpha-amino-beta-methyl-3-hydroxy-5-isoxazolepropionic acid (8), (RS)-alpha-amino-3-hy... |